¦b2011¦~5¤ë25¤é¡A¬ü°êÁp¨¹¨µ°j¤W¶Dªk°|¹ï©ó¨Ó¦Û¬ü°ê¥[¦{¥_°Ï¦a¤èªk°|ªº¤W¶D¡A±N¨äTherasense,
Inc. (²{¦W¬°¨È°ö¿}§¿¯f·ÓÅ@¨Æ·~¦³¤½¥q(Abbott
Diabetes Care, Inc.)) v. Becton, Dickinson and Co., No. 2008-1511, slip. op.®×¤¤¥þ°|ªk©xÁp®u§P¨Mµo§G(¬ü°êÁp¨¹¨µ°j¤W¶Dªk°|¡A2011¦~5¤ë25¤é)¡CÁp¨¹¨µ°jªk°|ºû«ùÂù¤e´ú¸Õ¡]two-prong
test¡^ªº°ò¥»µ²ºc¡A¥H¥D¾É¤£¥¿·í¦æ¬°¡]Inequitable
Conduct¡^ªº¥D±i¡CÁp¨¹ªk°|¥D±i«ÅºÙ¤£¥¿·í¦æ¬°ªº¤@¤è¥²¶·ÃÒ©ú¡G(1)±M§QÅv©Ò¦³¤Hªº§@¬°¦³©ú½T·N¹Ï´Û¿f±M§Q§½¡A¥H¤Î(2)©ÒÁô¿fªº¸ê°T¹ï©ó©Ò«ÅºÙ±M§Q¤§¥Ó½Ð±M§Q½d³òªº±M§Q©Ê«YÄÝ«n¡CµM¦Ó¡Aªk°|ÄÄ©ú¤Wz·N¹Ïn¥ó¨ÃÁY«n©Ên¥ó¡CÃö©ó·N¹Ïn¥ó¡Aªk°|§P©w¡§³Q«ü±±«IÅvªÌ¥²¶·¥H©ú½T¥B¯à¨Ï¤H«HªAªºÃÒ¾ÚÃÒ©ú¥Ó½Ð¤Hª¾±x¸Ó°Ñ¦Ò¤å¥ó¡Aª¾¹D¨ä«YÄÝ«n¡A¨Ã°µ¥X»W·NÁô¿f¸Ó°Ñ¦Ò¤å¥óªº¨M©w¡¨¡CÃö©ó«n©Ên¥ó¡Aªk°|»{¬°¡§«Ø¥ß¤£¥¿·í¦æ¬°©Ò¥²¶·ªº«n©Ê¬OY«D(but-for)«n©Ê¡¨¡C¡§YPTO¦¤wª¾±x¸Ó¥¼´¦ÅSªº¥ý«e§Þ³N¡A¨ä±N¤£·|®Öã¤@½Ð¨D¶µ¡A«h¸Ó¥ý«e§Þ³N¨ã¦³Y«D«n©Ê¡¨¡Cªk°|©ú½T¦a§_µ´´£¨Ñ©óUSPTO²Ä56±ø(37 C.F.R. ¡±1.56)¤¤¥B¥ý«e¥Ñ¶D³^·í¨Æ¤H¥Î©ó¹Á¸ÕÃÒ©ú¤£¥¿·í¦æ¬°ªº«n©Êªº©w¸q¡Cªk°|¥ç¶}³Ð¹ï©óY«D«n©Êªº¨Ò¥~®×¨Ò¡A¦b³o¨Ç¨Ò¥~®×¨Ò¤¤³Q§i¥i¥H«Ø¥ß¿n·¥´c½è¦æ¬°ªº¨Æ¹ê¡A¨äÃþ¦ü©ó«Ø¥ß¤£¼ä¤§¤â(Unclean
Hands)©Ò¥²¶·ªº¨Æ¹ê¡C¡]«ÝÄò¡^
|